Back
ESC Professional Premium Access

Impact of antihypertensive medication regimens on blood pressure control in individuals with established coronary heart disease

Session: Secondary prevention 2
Topic: Secondary Prevention
Speaker: Doctor S. Brennan (Dublin, IE)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Stephen Brennan

Mater Misericordiae University Hospital, Dublin (Ireland)
0 follower

6 more presentations in this session

Clinical routines for diabetes screening and treatment in cardiac rehabilitation improves detection and treatment of diabetes mellitus in patients with myocardial infarction

Speaker: Miss B. Sharad (Malmo, SE)

Access
Abstract
Slides
Like
Thumbnail

Improved adherence to statins following pictorial intervention. Sub study of visualization of subclinical atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA)

Speaker: Associate Professor H. Holmberg (Umea, SE)

Access
Abstract
Slides
Like
Thumbnail

Antiplatelet therapy use for the secondary prevention of cardiovascular disease in 2009-2017: a population-wide retrospective cohort study of Scotland

Speaker: Doctor I. Thalmann (Oxford, GB)

Access
Abstract
Slides
Like
Thumbnail

Effect of in-hospital nurse-led smoking cessation intervention for patients with atherosclerotic cardiovascular disease: a randomised pilot study

Speaker: Mrs K. Pleym (Drammen, NO)

Access
Abstract
Slides
Like
Thumbnail

Does low glycemic index diet superior than routine diet to control blood inflammation state and lipid parameters in patients with coronary artery disease?

Speaker: Doctor J. Uzokov (Tashkent, UZ)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Secondary prevention 2

Speakers: Doctor S. Brennan, Miss B. Sharad, Associate Professor H. Holmberg, Doctor I. Thalmann, Mrs K. Pleym...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources